Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Targeting deadly drug-resistant acinetobacter infections
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Dr. Lall brings extensive experience in healthcare operations, business strategy, and hospital management
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
Subscribe To Our Newsletter & Stay Updated
